Statistics

Total Visits

Views
FCGR2A/CD32A and FCGR3A/CD16A variants and EULAR response to tumor necrosis factor-alpha blockers in psoriatic arthritis: A longitudinal study with 6 months of followup89

Select a period of time:

Number of views in the range

Views
FCGR2A/CD32A and FCGR3A/CD16A variants and EULAR response to tumor necrosis factor-alpha blockers in psoriatic arthritis: A longitudinal study with 6 months of followup20

Views

Views
October 20252
November 20251
December 20256
January 20263
February 20260
March 20268
April 20260
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States7
United Kingdom6
Brazil3
Argentina1
China1
Spain1
Mauritius1
 

Top cities views

Views
Araras1
Ashburn1
Brooklyn1
Carapicuíba1
Córdoba1
Hoffman Estates1
Los Angeles1
Madrid1
McCook1
São Leopoldo1